Fabtech Technologies LimitedQ1 FY27 Results & Financial Update
Fabtech Technologies Limited: Q1 FY27 consolidated results and company financials – revenue ₹74.98 Cr, PAT ₹4.21 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Find an answer
Ask this result
Chart · Market context
Fabtech Technologies price & chart
Quarter overview
Quarterly earnings analysis
Fabtech Technologies Limited reported a consolidated revenue of ₹74.98 crore for the quarter ended June 30, 2026, marking a 10.3% year-on-year increase compared to ₹68.01 crore in Q1 FY26. The top-line expansion reflects consistent execution across key international markets despite the inherent seasonality of the EPC sector.
Management highlighted that a quiet first-quarter P&L is characteristic of the engineering and project construction industry, where activity is seasonally concentrated in the second half of the fiscal year and revenue recognition depends strictly on milestone-based equipment shipments rather than linear quarterly distribution.
Contribution margins expanded notably to 46.7%, representing an increase of approximately 910 basis points compared to 37.6% in Q1 FY26. This margin enhancement was driven by disciplined project selection, enhanced procurement efficiencies, and a favorable scope mix leaning toward higher-value engineering and design content.
Cost discipline further supported the bottom-line turnaround, with employee costs declining by 2.8% year-on-year to ₹10.22 crore, signaling early emergence of operating leverage. Finance costs decreased significantly by 35.9% to ₹0.84 crore, aided by the efficient utilization of post-IPO funds.
Regional performance showed divergent trends across key geographies. While the UAE market experienced temporary regional headwinds, operations in Saudi Arabia demonstrated stellar growth with a 130% year-on-year increase to ₹17.13 crore, and the African markets contributed ₹27.93 crore combined through scale-ups in Morocco and Kenya, alongside a strong turnaround in the core standalone business.
Profit after tax was ₹4.21 Cr for the reported quarter. EPS was ₹0.95 for the reported quarter.
01 · Business model
What does Fabtech Technologies do?
Fabtech Technologies Limited serves as a global turnkey solutions provider specialising in the life sciences, pharmaceutical, biotechnology, and healthcare sectors. The company integrates design, engineering, in-house manufacturing, and validation across its core pillars of Process Equipment & Containment Systems, Cleanrooms, and Purified Water & Distribution.
Operating through an asset-light and integrated business model, the company minimizes third-party dependency to deliver contamination-controlled environments and GMP-compliant infrastructure across more than 60 countries. Its project execution typically spans 12 to 36 months, with revenues recognized upon milestone achievement and equipment shipments.
Geographically, the group derives a significant share of its revenue from international markets, particularly the Middle East and Africa, supported by specialized operating entities such as FTS Cleanroom Systems LLC in the UAE and regional subsidiaries across Saudi Arabia and Africa.
02 · Historical context
What shaped the business before this quarter
The company has built three decades of engineering expertise, expanding its operational footprint across 60+ countries and establishing dedicated overseas subsidiaries and joint ventures.
Following its initial public offering, the company deployed proceeds toward working capital efficiency and debt reduction, resulting in lowered finance costs entering FY27.
03 · Financial snapshot
Current-quarter financial snapshot
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹74.98 Cr |
| Total income | ₹78.15 Cr |
| Profit before tax | ₹0.00 Cr |
| Profit after tax | ₹4.21 Cr |
| EPS | ₹0.95 |
04 · Why it moved
Why the quarter looked the way it did
What drove revenue
Revenue was bolstered by robust execution in international territories, led by a 130% year-on-year surge in Saudi Arabia to ₹17.13 crore and strong contributions of ₹27.93 crore from Morocco and Kenya combined.
The core FTL standalone business achieved a notable operational turnaround on a year-on-year basis, complementing the broader international scale-up.
What drove margins
Contribution margin reached 46.7% in Q1 FY27, expanding by 910 basis points YoY from 37.6% in Q1 FY26, driven by favorable scope mix, disciplined tendering, and tighter vendor frameworks.
Employee expenses reduced by 2.8% year-on-year to ₹10.22 crore, reflecting operational efficiency and better staff utilization relative to revenue scale.
Finance costs fell 35.9% year-on-year to ₹0.84 crore, supported by post-IPO fund deployment and capital preservation.
05 · Demand, customers & order book
Where demand is coming from
The open order book stood at over ₹900 crore as of June 30, 2026, providing multi-year visibility over the next two years.
The company secured ₹96.5 crore in new order inflows during Q1 FY27, of which ₹8.4 crore originated from repeat clients.
Active enquiries exceeded ₹9,300 crore, supported by ₹3,800+ crore in hot leads, reflecting sustained project demand despite geopolitical delays in finalising certain contract awards.
06 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
The company maintained its focus on integrated turnkey delivery encompassing cleanrooms, HVAC, process equipment, and pure water systems for pharmaceutical and life sciences clients.
Geography and market mix
International revenue accounts for approximately 55% of the total footprint across 60+ countries, with FY26 full-year mix indicating 29.6% from Rest of World, 27.9% from UAE, 18.2% from Saudi Arabia, 10.0% from India, 9.6% from Kenya, and 4.8% from Morocco.
Severe regional headwinds and pressure in the UAE market were successfully absorbed and offset by stellar growth in Saudi Arabia (+130% YoY) and expanding operations across African markets.
07 · Capacity, projects & execution
What is being built, commissioned or delivered
Capacity, production and utilisation
The company operates an asset-light, integrated manufacturing model encompassing Process Equipment & Containment Systems, Cleanrooms, and Purified Water systems to ensure quality control and reduce import dependencies.
Projects, capex and execution
Capital expenditure and working capital are deployed strictly in alignment with actual project execution requirements and order book growth.
08 · Strategy & new businesses
How the company is trying to change its growth mix
The group continues to deepen its presence in the GCC, East Africa, and South-East Asia, utilizing Fabtech Lifecare as a vehicle for geography-led growth.
Post-IPO proceeds are directed toward adopting digital tools across design, commissioning, and data infrastructure alongside structured leadership hiring.
09 · Reported developments
What changed operationally
Contribution margin reached a record 46.7%, improving by 910 basis points YoY.
Delivered 130% year-on-year growth in Saudi Arabia, reaching ₹17.13 crore in Q1 revenue.
10 · Pressure points & risks
What is not going smoothly
The UAE market (FTS) experienced severe regional pressure, though it was offset by diversification into Saudi Arabia and Africa.
Geopolitical factors temporarily delayed the finalisation of certain order awards, though customer engagement remains highly active with zero cancellations.
11 · Cash flow & balance sheet
Profit is one thing. Cash and funding tell another part of the story.
Working capital is released in line with active project milestones, while capital awaiting deployment is parked in bank fixed deposits to ensure capital preservation and stable returns.
Capital allocation & funding
Effective deployment of post-IPO funds has successfully reduced debt-servicing burdens, lowering quarterly finance costs to ₹0.84 crore.
12 · Management guidance & targets
What management is targeting from here
Management expects 20–25% expected YoY organic growth for the current fiscal year, underpinned by the robust order pipeline and business visibility.
Management noted that Q2 is expected to remain steady, with stronger performance anticipated in H3 and H4 as project execution accelerates and deferred orders are finalized.
13 · Beyond the numbers
What changed beyond the numbers
Industry Tailwinds
Growth is supported by accelerating biologics and specialty pharma capex, healthcare infrastructure investments in the GCC and Africa, regulatory pressure driving global facility upgrades, and China+1 supply chain diversification strategies.
14 · Previous-quarter changes
What changed since the previous quarter
As typical for EPC businesses where Q4 marks the seasonal peak, revenue moderated sequentially compared to Q4 FY26 due to milestone-based shipping schedules, while maintaining a healthy YoY trajectory.
15 · Key Q&A
The quarter, answered directly
What does Fabtech Technologies do?
Fabtech Technologies Limited serves as a global turnkey solutions provider specialising in the life sciences, pharmaceutical, biotechnology, and healthcare sectors. The company integrates design, engineering, in-house manufacturing, and validation across its core pillars of Process Equipment & Containment Systems, Cleanrooms, and Purified Water & Distribution.
What is the clearest takeaway from Q1 FY27?
Fabtech Technologies Limited reported a consolidated revenue of ₹74.98 crore for the quarter ended June 30, 2026, marking a 10.3% year-on-year increase compared to ₹68.01 crore in Q1 FY26. The top-line expansion reflects consistent execution across key international markets despite the inherent seasonality of the EPC sector.
What drove revenue or demand?
Revenue was bolstered by robust execution in international territories, led by a 130% year-on-year surge in Saudi Arabia to ₹17.13 crore and strong contributions of ₹27.93 crore from Morocco and Kenya combined.
What mattered most for margins or profitability?
Contribution margin reached 46.7% in Q1 FY27, expanding by 910 basis points YoY from 37.6% in Q1 FY26, driven by favorable scope mix, disciplined tendering, and tighter vendor frameworks.
What changed operationally beyond the headline numbers?
The company operates an asset-light, integrated manufacturing model encompassing Process Equipment & Containment Systems, Cleanrooms, and Purified Water systems to ensure quality control and reduce import dependencies.
What is management guiding or targeting from here?
Management expects 20–25% expected YoY organic growth for the current fiscal year, underpinned by the robust order pipeline and business visibility.
16 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
17 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Conversion of Hot Leads and Enquiries: Monitor the conversion of the ₹3,800+ crore hot leads pipeline and ₹9,300+ crore active enquiries into firm order inflows.
- 02
H2 Execution Acceleration: Track the anticipated acceleration in project execution and finalization of deferred orders during the second half of FY27.
- 03
International Market Trajectory: Observe the continued expansion in Saudi Arabia and African markets alongside the stabilization of UAE operations.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.
